Antiviral therapy and resistance with hepatitis B virus infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

304

HTML

1797

Figures (1-7)

309

Tables (1-2)

205

Sum=2615

Jan 7, 2007 (publication date) through Jan 5, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 7, 2007; 13(1): 125-140
Published online Jan 7, 2007. doi: 10.3748/wjg.v13.i1.125

Table 1 Indication for observing and treating HBV

	HBV-DNAlevels	ALT status	Therapy/Observation
HBeAg +	> 10⁵	Normal	Observe
HBeAg +	> 10⁵	Elevated	Yes	IFN, Antivirals
HBeAg +	> 10⁴	Normal	Observe
HBeAg -	> 10⁴	Elevated	Yes	Antivirals, IFN
HBeAg -	> 10⁴	Normal	Observe
Pregnancy	> 10⁹ geq/mL	Irrelevant	Yes	Antivirals
HBsAg + chemotherapy	Irrelevant	Irrelevant	Yes	Antivirals
HBsAg -
Anti-HBc + chemotherapy	Positive	Irrelevant	Observe, treat in case of HBs-Ag appearance	Antivirals
Advanced fibrosis	irrelevant	Elevated	Always	Antivirals
Transplanted patients	> 10⁴		Consider Treatment	Antivirals
Asian male	> 10^5/6	Irrelevant	Yes	Antivirals

Citation: Tillmann HL. Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 2007; 13(1): 125-140
URL: https://www.wjgnet.com/1007-9327/full/v13/i1/125.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i1.125